Module 1: GIST primary and recurrent
Available from September 2026
Module 1: GIST primary and recurrent
Available from September 2026
29/09/2026
Biology of GIST
29/09/2026
Pathological and molecular diagnosis
29/09/2026
Surgery of GIST
29/09/2026
Management of primary localized disease
29/09/2026
Management of metastatic disease
29/09/2026
New drugs and clinical trials
29/09/2026
Rare GIST subtypes
29/09/2026
Monitoring advanced GIST with circulating tumor DNA
29/09/2026
Current controversies
29/09/2026
Understanding KIT inhibitors resistance
29/09/2026
Clinical case discussion (live online session)
Module director: Mehdi Brahmi, FR
Dimitri Tzanis
Institute Curie, Sarcoma Dpt., Paris, FR
George Demetri
Dana-Farber Cancer Institute, Sarcoma Dpt., Boston, US
Giovanni Grignani
FPO - IRCCS Candiolo, Oncology Dpt., Candiolo, IT
Javier Martin Broto
Fundación Jimenez Diaz University Hospital, Oncology Dpt., Madrid, ES
Jean-Michel Coindre
Institut Bergonié, Pathology Dpt., Bordeaux, FR
Jean-yves Blay
University Claude Bernard Lyon I, Centre Léon Bérard, Dept. of Medicine, Lyon, FR
Nadia Hindi
Hospital Fundación Jimenez Díaz, Medical Oncology, Madrid, ES
Peter Reichardt
Helios Clinic Berlin-Buch, Sarcoma Dpt., Berlin, DE
Susanne George
Dana-Farber Cancer Institute, Sarcoma Dpt., Boston, US
